Medication info
Bonogro Tablet 150 mg (Risedronate Sodium 2.5 Hydrate)

Bonogro Tablet 150 mg (Risedronate Sodium 2.5 Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›172.1mg / 1 tablet
Manufacturer / importer
Hanol BioPharma Co., Ltd.
Appearance
Bright blue rectangular film-coated tablet
Packaging
1 tablet/PTP
Approval status
Active

MFDS item code 201004244 · Notified 2010.06.30 · Insurance code 655604220

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
Adults: Administer 150 mg of risedronate sodium orally once monthly. Older adults: No dosage adjustment is necessary in older adults (over 60 years of age), because the bioavailability and pharmacodynamics of this drug are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. Because food interferes with the absorption of this drug, take it at least 30 minutes before the first food or beverage other than water of the day to ensure adequate absorption. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it while upright with a sufficient amount of plain water (170 ∼ 230 mL). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck the tablet because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take this drug on the scheduled day, take it as follows. If the next scheduled dose is 7 days or more away, take 1 tablet the morning after remembering. Resume taking the next dose on the originally scheduled day. Do not take more than 1 tablet of this drug within 7 days. If the next scheduled dose is less than 7 days away, wait until the originally scheduled day and take 1 tablet of this drug.
Child dose
Under 18 years: The safety and efficacy in children under 18 years of age have not been established.

Ingredients

Manufacturer
Hanol BioPharma Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women. Osteoporosis is a disease characterized by weakened bones and an increased risk of fractures, which is particularly common among postmenopausal women. Taking this medication helps maintain bone strength and reduce the risk of fractures. It is available in tablet form in two dosages: 75 mg and 150 mg, allowing appropriate use according to the patient's condition. Regular use can effectively prevent the progression of osteoporosis and maintain healthy bones.

How to take

Adult dose

Adults: Administer 150 mg of risedronate sodium orally once monthly. Older adults: No dosage adjustment is necessary in older adults (over 60 years of age), because the bioavailability and pharmacodynamics of this drug are similar to those in younger people. Patients with renal impairment: No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. Because food interferes with the absorption of this drug, take it at least 30 minutes before the first food or beverage other than water of the day to ensure adequate absorption. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it while upright with a sufficient amount of plain water (170 ∼ 230 mL). Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck the tablet because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. If a patient forgets to take this drug on the scheduled day, take it as follows. If the next scheduled dose is 7 days or more away, take 1 tablet the morning after remembering. Resume taking the next dose on the originally scheduled day. Do not take more than 1 tablet of this drug within 7 days. If the next scheduled dose is less than 7 days away, wait until the originally scheduled day and take 1 tablet of this drug.

Child dose

Under 18 years: The safety and efficacy in children under 18 years of age have not been established.

Precautions

This medication can irritate the stomach and esophagus, so patients with upper gastrointestinal diseases such as gastritis, esophagitis, or esophageal ulcers should take it with caution. It must be taken with a sufficient amount of water, and patients should avoid lying down for at least 30 minutes after taking the medicine. If there are issues with the esophagus or symptoms of dysphagia occur, the medication should be stopped immediately, and a doctor should be consulted. Patients with esophageal motility disorders, hypersensitivity to this drug, hypocalcemia, pregnant or potentially pregnant women, breastfeeding women, and those with severe renal impairment should not take this medication. This medication contains lactose, so patients with lactose intolerance should avoid it. As a bisphosphonate, serious side effects such as osteonecrosis of the jaw, atypical femoral fractures, and severe gastrointestinal bleeding can rarely occur; any unusual symptoms should be reported to healthcare professionals immediately. Taking this medication with food or medications containing divalent cations such as calcium, magnesium, iron, or aluminum can interfere with its absorption, so a sufficient interval should be maintained. Pregnant or breastfeeding women should avoid taking this medicine or consult a specialist, and safety in children under 18 has not been established. In case of overdose, symptoms of hypocalcemia may appear, and immediate medical attention should be sought for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to another container.

Side effects

  • Esophagitis
  • esophageal ulcers
  • esophageal erosions
  • esophageal obstruction
  • esophageal perforation
  • bleeding
  • infection
  • low back pain
  • accidental injury
  • pain
Show 57 more
  • abdominal pain
  • flu symptoms
  • headache
  • weakness
  • throat pain
  • chest pain
  • allergic reactions
  • hypertension
  • constipation
  • diarrhea
  • dyspepsia
  • nausea
  • peripheral edema
  • arthralgia
  • arthritis
  • fractures
  • joint abnormalities
  • myalgia
  • bone pain
  • dizziness
  • depression
  • insomnia
  • bronchitis
  • sinusitis
  • rhinitis
  • pharyngitis
  • increased cough
  • rash
  • cataracts
  • urinary tract infection
  • vomiting
  • uveitis
  • scleritis
  • iritis
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • Riel syndrome
  • angioedema
  • blisters
  • skin reactions
  • osteonecrosis of the jaw
  • liver dysfunction
  • jaundice
  • loss of appetite
  • myasthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • eye pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air exposure, ideally at room temperature between 1 and 30 degrees Celsius. Storing it this way can help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

Bright blue rectangular film-coated tablet

Package unit

1 tablet/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.